Clinical Safety Laboratory

Introduction

The Clinical Safety Laboratory (Safety Lab) operated within the HelixLab and Omega CRO ecosystem provides standardized, protocol-compliant laboratory assessments required to monitor participant safety throughout clinical research programs. Safety laboratory testing constitutes a core component of clinical trial oversight, enabling early detection of treatment-related risks and supporting data-driven safety decisions.

Laboratory, analytical, and operational services provided within the Omega ecosystem are delivered through Omega’s internal units or authorized partner infrastructures that comply with applicable standards, depending on the nature of the study, regulatory requirements, and methodological scope. Accreditations, certifications, and official authorizations apply at the level of the unit or partner organization where the service is actually performed and are assessed on a study-specific basis for each service category.

 

Scope of Safety Laboratory Services

Safety Lab services are designed to support Phase I through Phase IV clinical trials across diverse therapeutic areas, with all testing workflows structured to ensure consistency, traceability, and timely reporting. These services include hematology and coagulation testing, comprehensive clinical biochemistry and metabolic panels, urinalysis and renal safety monitoring, as well as study-specific serology and infection screening. In addition, drug screening and toxicology analyses are performed as required based on protocol specifications.

Regulatory Compliance and Quality Framework

Safety Lab operations are conducted in full alignment with international regulatory and quality standards, ensuring audit readiness and data integrity. These activities are carried out in accordance with International Council for Harmonisation Good Clinical Practice (ICH GCP) and Good Laboratory Practice (GLP) principles, while the ALCOA+ data integrity framework is applied throughout all processes. In addition, comprehensive audit trail systems and chain-of-custody documentation are maintained to ensure full traceability and compliance.

Data Management, Reporting, and Integration

Safety laboratory data are generated, reviewed, and reported within predefined timelines to support real-time safety oversight and regulatory reporting. Protocol-specific reference ranges and flagging mechanisms are applied to identify clinically relevant findings, while electronic data transfer processes are aligned with sponsor Electronic Data Capture (EDC) and electronic Case Report Form (eCRF) systems. In addition, structured query resolution and data clarification workflows are maintained, and both interim and final safety reports are produced in accordance with study requirements.

The flow cytometry workflow is conducted in accordance with end-to-end traceability and auditability principles, from sample receipt through reporting.

  • Sample collection and labeling: Ensuring correct sample-to-participant matching.
  • Transport and receipt: Monitoring and documentation of time and temperature conditions.
  • Sample preparation: Protocol-compliant processing, staining, and assay execution.
  • Data acquisition and generation: Data collection under standardized conditions.
  • Data review and reporting: Delivery of results in protocol-defined formats.

    Hematological parameters are essential for monitoring bone marrow function, immune status, and bleeding risk. Testing is performed using validated automated analyzers under strict quality control.

    • Complete blood count (CBC) with differential
    • Hemoglobin, hematocrit, and platelet counts
    • Coagulation parameters including PT, aPTT, and INR

Clinical chemistry analyses provide insight into organ function and metabolic balance, supporting safety assessments throughout the study lifecycle.

  • Liver function tests (ALT, AST, ALP, bilirubin)
  • Renal function markers (creatinine, urea, eGFR)
  • Electrolytes, glucose, and lipid profiles
  • Cardiac and muscle enzymes when required by protocol
    •  

Urinalysis is integrated into safety monitoring to assess renal function, hydration status, and potential drug-related nephrotoxicity.

  • Routine dipstick analysis.
  • Microscopic sediment examination.
  • Protein, glucose, ketone, and blood detection.

Pre-analytical and analytical processes are standardized to minimize variability and ensure result reliability. All samples are handled according to predefined acceptance and rejection criteria.

  • Standardized sample collection and labeling.
  • Controlled transport and temperature monitoring.
  • Automated analysis with internal quality controls.
  • Deviation management and corrective actions (CAPA).